XML 50 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation, Stock Options and Stock Appreciation Rights Award Activity
The following table presents certain information related to the activity of our non-vested stock option grants:
Number of Stock OptionsWeighted Average Exercise PricesWeighted Average Remaining Contractual Term (years)Aggregate Intrinsic Value
Outstanding as of December 31, 20211,147,215 $4.80 9.49 $792,000 
Granted635,643 1.70 — — 
  Less: Forfeited199,006 3.05 — — 
  Less: Expired— — — — 
Less: Exercised
— — — — 
Outstanding as of September 30, 2022
1,583,852 $3.77 9.05 $— 
Vested as of September 30, 2022(1)
463,724 $7.77 8.19 $— 
Exercisable as of September 30, 2022
411,090 $6.36 8.44 $— 
(1) The vested shares are calculated based on all vested shares at September 30, 2022, inclusive of those that have since expired. The weighted average exercise prices and weighted-average remaining contractual term is calculated based on only vested shares that are outstanding and exercisable at September 30, 2022.
Schedule of Nonvested Share Activity
The following table presents certain information related to the activity of our non-vested common stock grants:
Number of Restricted SharesWeighted Average Grant Date Fair Value
Outstanding as of December 31, 2021336,596 $6.99 
Granted 907,907 1.97 
Less: Forfeited208,075 4.31 
Less: Vested 112,722 7.09 
Outstanding as of September 30, 2022
923,706 $2.65 
Share-based Payment Arrangement, Activity
The following table presents our total stock-based compensation expense:
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Employee stock-based compensation expense
     Pre-tax $261 $270 $792 $495 
     Post-tax (1)
206 213 626 391 
Director stock-based compensation expense
     Pre-tax 29 66 132 243 
     Post-tax (1)
23 52 104 192 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The following weighted-average assumptions were used to value the stock options granted:
20222021
Expected annual dividend yield—  %0.65  %
Expected volatility49.66  %46.63  %
Risk-free interest rate2.92  %1.16  %
Expected term6 years6 years